Status:
UNKNOWN
CuMulativE Live bIrth Rate of Patients at High Risk of OHSS After Freeze-all Embryos at Cleavage or blAstocyst Stage
Lead Sponsor:
Université Libre de Bruxelles
Collaborating Sponsors:
Aristotle University Of Thessaloniki
Conditions:
Infertility
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Ovarian stimulation for the induction of multifollicular growth by gonadotrophins represents an important part of In Vitro Fertilization (IVF). However, the use of these drugs can be associated with s...
Eligibility Criteria
Inclusion
- Patients \<40 years old
- Indication for In Vitro Fertilisation (IVF)/Intracytoplasmic sperm injection (ICSI)
- No more than 2 previous failed IVF/ICSI cycles
- Stimulation in GnRH antagonist cycle
- Presence of ≥16 follicles of \>10mm on the day of triggering of final oocyte maturation
- GnRH agonist trigger (triptorelin 0.2mg)
Exclusion
- Cycles with testicular sperm extraction
- Preimplantation genetic diagnosis
- Patients with uterine malformations
- Patients with infectious diseases
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT03817060
Start Date
February 1 2019
End Date
February 1 2021
Last Update
January 25 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.